Quantcast

Latest Peptides Stories

2011-08-05 00:00:30

American Peptide Company recently began a collaboration with Sandia Biotech to synthesize peptides to be used in their Split Green Fluorescent Protein (sGFP) detection system. Sunnyvale, CA (PRWEB) August 04, 2011 American Peptide Company recently began a collaboration with Sandia Biotech to synthesize peptides to be used in their Split Green Fluorescent Protein (sGFP) detection system. The split GFP technology consists of a 16 amino acid fusion tag and a complementary protein to detect the...

2011-07-27 08:00:00

MATTHEWS, N.C., July 27, 2011 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation, continues to see strong success with its microwave peptide synthesis products. In FY2011 year-to-date, the company has seen significant growth versus the prior year in its automated peptide synthesizer instrument sales and is on pace to easily sell a record number of systems. Additionally, CEM's products were well received at the recent American Peptide...

2011-07-26 00:00:28

Doctor Stephen Langer has teamed up with Swanson Health Products to exclusively offer a glutathione-boosting supplement program complete with organic, undenatured whey protein powder. Fargo, ND (PRWEB) July 25, 2011 Glutathione, a powerful intracellular antioxidant, has traditionally been overlooked in the field of nutritional supplements because it was believed to be ineffective. Together with Swanson Health Products, Dr. Stephen Langer is changing the way we approach glutathione...

2011-06-25 00:00:31

American Peptide Company, a leading innovator in peptide manufacturing and peptide-based services, is a Gold Sponsor at the 22nd American Peptide Symposium which will be held on June 25-30, 2011 at the Sheraton Hotel and Marina in San Diego, California. Sunnyvale, CA (PRWEB) June 24, 2011 American Peptide Company, a leading innovator in peptide manufacturing and peptide-based services, is a Gold Sponsor at the 22nd American Peptide Symposium which will be held on June 25-30, 2011 at the...

2011-06-23 16:06:00

DUBLIN, Ireland and LEXINGTON, Massachusetts, June 23, 2011 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) recommended, by a vote of twelve to one, that the efficacy and safety data provides substantial evidence to support approval of FIRAZYR(R) (icatibant) for the treatment of acute attacks of hereditary...

2011-06-22 06:30:00

HYDERABAD, India, June 22, 2011 /PRNewswire/ -- Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract research and manufacturing services to customers located in 85 countries, today announced it will unveil its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego June 25-30, 2011. "It is fitting that we formally launch our new...

2011-06-21 06:30:00

CRANBURY, N.J., June 21, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 7,964,181, titled "Amino Acid Surrogates for Peptidic Constructs." The claims in the issued patent cover a series of small molecule mimics for naturally occurring amino acids which can be used as building blocks in drug development. A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's...

2011-06-14 07:00:00

MONTREAL, June 14, 2011 /PRNewswire/ - Immunotec Inc. (TSXV: IMM) (www.immunotec.com/IRL/Public/en/CAN/science_research.wcp) announces that data from research using Immunocal® in a mouse model by Principal Investigator Daniel Linseman, PhD and his team at the University of Denver in Colorado shows promise in delaying the onset of amyotrophic lateral sclerosis. Investigators studied mice harbouring the gene that is responsible for some forms of the disease commonly...

2011-06-02 12:44:33

Who would have thought that Gila monster saliva would be the inspiration for a blockbuster new drug for Type 2 diabetes? Or that medicines for chronic pain, heart attacks, high blood pressure and stroke would emerge from venom of the Magician's cone snail, the saw-scaled viper, the Brazilian lancehead snake and the Southeastern pygmy rattlesnake? These are just some of the sources contributing to the emergence of potential new drugs based on "peptides" that is the topic of the cover story in...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'